Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease.
Journal
Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R
Informations de publication
Date de publication:
15 06 2020
15 06 2020
Historique:
received:
04
04
2019
accepted:
05
04
2020
pubmed:
26
4
2020
medline:
13
2
2021
entrez:
26
4
2020
Statut:
ppublish
Résumé
Defects in biliary transport proteins, MDR3 in humans and Mdr2 in mice, can lead to a spectrum of cholestatic liver disorders. Although B cell disorders and the aberrant Ab production are the leading extrahepatic manifestations of cholestatic liver diseases, the mechanism underlying this phenomenon is incompletely understood. Using mice with deficiency of Mdr2 that progressively develop cholestatic liver disease, we investigated the contributions of BAFF to aberrant IgG autoantibody production and hepatic fibrosis. In
Identifiants
pubmed: 32332110
pii: jimmunol.1900391
doi: 10.4049/jimmunol.1900391
pmc: PMC7306885
mid: NIHMS1598784
doi:
Substances chimiques
Autoantibodies
0
B-Cell Activating Factor
0
Immunoglobulin G
0
Receptors, Antigen, B-Cell
0
Tnfsf13b protein, mouse
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3117-3128Subventions
Organisme : NIAID NIH HHS
ID : P30 AI050409
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136533
Pays : United States
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NCRR NIH HHS
ID : P51 RR000165
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI096882
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK109025
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI126890
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124680
Pays : United States
Informations de copyright
Copyright © 2020 by The American Association of Immunologists, Inc.
Références
Nat Methods. 2013 Apr;10(4):325-7
pubmed: 23435259
Eur J Clin Invest. 2001 Jul;31(7):628-38
pubmed: 11454019
Hepatology. 2009 Dec;50(6):1893-903
pubmed: 19877182
Ann Hepatol. 2014 May-Jun;13(3):384-9
pubmed: 24756015
J Clin Invest. 2017 May 1;127(5):1651-1663
pubmed: 28346226
Annu Rev Immunol. 2003;21:231-64
pubmed: 12427767
J Hepatol. 2015 May;62(5):1148-55
pubmed: 25477264
Cytokine Growth Factor Rev. 2002 Feb;13(1):19-25
pubmed: 11750877
J Immunol. 2016 May 1;196(9):3525-31
pubmed: 27022196
N Engl J Med. 2016 Sep 22;375(12):1161-70
pubmed: 27653566
Hepatology. 2002 Dec;36(6):1393-9
pubmed: 12447864
Gastroenterology. 2018 Jun;154(8):2178-2193
pubmed: 29454797
Cytokine. 2015 Dec;76(2):537-544
pubmed: 26198030
Hepatology. 1999 Feb;29(2):543-7
pubmed: 9918933
Hepatology. 2012 Feb;55(2):512-21
pubmed: 22006563
Gastroenterology. 2010 Nov;139(5):1481-96
pubmed: 20849855
J Immunol. 2005 Mar 1;174(5):3015-23
pubmed: 15728515
Zhonghua Yi Xue Za Zhi. 2007 Jan 9;87(2):128-30
pubmed: 17418023
Hepatol Commun. 2018 Aug 06;2(8):956-967
pubmed: 30094406
Front Immunol. 2018 Nov 02;9:2534
pubmed: 30450101
Immunity. 2006 Sep;25(3):429-40
pubmed: 16973388
Clin Immunol. 2010 Feb;134(2):217-25
pubmed: 19840904
Curr Opin Immunol. 2008 Apr;20(2):158-61
pubmed: 18456486
Curr Opin Immunol. 1996 Apr;8(2):206-14
pubmed: 8725944
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11249-53
pubmed: 7479974
Auto Immun Highlights. 2016 Dec;7(1):1
pubmed: 26831867
Hepatology. 2012 Mar;55(3):709-19
pubmed: 21932384
PLoS One. 2016 Mar 03;11(3):e0150606
pubmed: 26938654
J Immunol. 2010 Oct 1;185(7):4128-36
pubmed: 20817867
Hepatology. 2015 Jun;61(6):2067-79
pubmed: 25711908
Immunol Lett. 2003 Jul 3;88(1):57-62
pubmed: 12853163
J Exp Med. 1999 Jun 7;189(11):1747-56
pubmed: 10359578
Best Pract Res Clin Gastroenterol. 2018 Jun - Aug;34-35:85-94
pubmed: 30343714
Hepatology. 2017 Feb;65(2):661-677
pubmed: 27774611
Blood. 1994 Nov 1;84(9):3047-53
pubmed: 7949176
J Hepatol. 1995 Jun;22(6):696-9
pubmed: 7560864
Nat Rev Immunol. 2002 Jul;2(7):465-75
pubmed: 12094221
Clin Exp Immunol. 2012 Nov;170(2):231-7
pubmed: 23039894
J Immunol. 2003 Nov 1;171(9):4639-49
pubmed: 14568938
Gastroenterology. 2004 Jul;127(1):261-74
pubmed: 15236191
Hum Immunol. 2007 Jul;68(7):586-91
pubmed: 17584580
Cell. 1993 Nov 5;75(3):451-62
pubmed: 8106172
Clin Dev Immunol. 2012;2012:638185
pubmed: 22956970
J Immunol. 2016 Dec 15;197(12):4848-4858
pubmed: 27849172
J Immunol Res. 2015;2015:247426
pubmed: 25866827
J Clin Invest. 2005 Nov;115(11):3072-82
pubmed: 16276416
Curr Gastroenterol Rep. 2006 Feb;8(1):75-82
pubmed: 16510038
World J Gastroenterol. 2008 Jun 28;14(24):3781-91
pubmed: 18609700
Scientifica (Cairo). 2012;2012:
pubmed: 23807906
Hepatology. 2018 May;67(5):1970-1985
pubmed: 29105104
Clin Liver Dis. 2016 Feb;20(1):79-98
pubmed: 26593292
Clin Exp Immunol. 2009 Nov;158(2):155-63
pubmed: 19737141
J Exp Med. 2007 Aug 6;204(8):1959-71
pubmed: 17664289
J Immunol. 2007 Jun 15;178(12):7531-9
pubmed: 17548587
Nat Rev Immunol. 2009 Sep;9(9):657-61
pubmed: 19704418
J Autoimmun. 2015 Aug;62:1-10
pubmed: 26103922
Blood. 2008 Feb 1;111(3):1344-56
pubmed: 17942751
PLoS One. 2013 Jun 28;8(6):e68308
pubmed: 23840845
Scand J Rheumatol. 2019 Mar;48(2):149-156
pubmed: 30270699
Am J Gastroenterol. 2013 Jun;108(6):933-41
pubmed: 23649186